{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:25:28Z","timestamp":1791033928572,"version":"4.1.0"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T00:00:00Z","timestamp":1319155200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0026375","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T21:30:48Z","timestamp":1319232648000},"page":"e26375","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy"],"prefix":"10.1371","volume":"6","author":[{"given":"Daniela Silva","family":"Moura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Montestruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gineste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Barete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Moussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,10,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal.","volume":"25","author":"P Valent","year":"2001","journal-title":"Leuk Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2559.1979.tb03017.x","article-title":"Mast cells and mast cell neoplasia: a review.","volume":"3","author":"K Lennert","year":"1979","journal-title":"Histopathology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status.","volume":"96","author":"DD Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.","volume":"37","author":"P Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","article-title":"Mast cell proliferative disorders: current view on variants recognized by the World Health Organization.","volume":"17","author":"P Valent","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.beha.2005.07.010","article-title":"Pathogenesis, clinical features, and treatment advances in mastocytosis.","volume":"19","author":"A Pardanani","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e2266","DOI":"10.1371\/journal.pone.0002266","article-title":"Case-control cohort study of patients' perceptions of disability in mastocytosis.","volume":"3","author":"O Hermine","year":"2008","journal-title":"PLoS ONE"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bbrc.2005.09.150","article-title":"Structure and regulation of Kit protein-tyrosine kinase\u2014the stem cell factor receptor.","volume":"338","author":"R Roskoski Jr","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2005.08.055","article-title":"Signaling by Kit protein-tyrosine kinase\u2014the stem cell factor receptor.","volume":"337","author":"R Roskoski Jr","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/neuonc\/noq003","article-title":"Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas.","volume":"12","author":"E Tamborini","year":"2010","journal-title":"Neuro Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1358\/dof.2008.033.02.1164207","article-title":"Kit mutations in cancer and their treatment with protein kinase inhibitors.","volume":"33","author":"U Tests","year":"2008","journal-title":"Drugs Fut"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1634\/stemcells.2004-0117","article-title":"Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit.","volume":"23","author":"J Lennarttson","year":"2005","journal-title":"Stem Cells Dev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/1541-7786.MCR-08-0067","article-title":"Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors.","volume":"6","author":"S Letard","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Bodemer C, Hermine O, Palmerini F, Yang Y, Grandpeix-Guyodo C, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.","volume":"130","journal-title":"J Invest Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1371\/journal.pone.0001906","article-title":"Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.","volume":"3","author":"F Lanternier","year":"2008","journal-title":"PLoS ONE"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e7258","DOI":"10.1371\/journal.pone.0007258","article-title":"Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.","volume":"4","author":"P Dubreuil","year":"2009","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000048180","article-title":"Histopathological and immunohistochemical aspects of mastocytosis.","volume":"127","author":"HP Horny","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.wnl.0000168897.35545.61","article-title":"Systemic mastocytosis: a potential neurologic emergency.","volume":"65","author":"GB Boncoraglio","year":"2005","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00004714-200204000-00019","article-title":"Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis.","volume":"22","author":"C Pehlivanidis","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00415-004-0505-1","article-title":"Parkinsonism due to bilateral basal ganglia lesions following mastocytosis-induced hypoxia.","volume":"251","author":"A Schramm","year":"2004","journal-title":"J Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1468-3083.2000.00018.x","article-title":"Familial mastocytosis associated with neurosensory deafness.","volume":"14","author":"G Trevisan","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11259-009-9231-6","article-title":"Pharmacokinetics of masitinib in cats.","volume":"33","author":"F Bellamy","year":"2009","journal-title":"Vet Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1939-1676.2008.0190.x","article-title":"Masitinib is safe and effective for the treatment of canine mast cell tumors.","volume":"22","author":"KA Hahn","year":"2008","journal-title":"J Vet Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.21894","article-title":"Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.","volume":"85","author":"C Paul","year":"2010","journal-title":"Am J Hematol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00006842-198607000-00006","article-title":"Mixed organic brain syndrome as a manifestation of systemic mastocytosis.","volume":"48","author":"MP Rogers","year":"1986","journal-title":"Psychosom Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1477-7525-8-104","article-title":"Health care providers underestimate symptom intensities of cancer patients: A multicenter European study.","volume":"8","author":"EA Laugsand","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s005200100244","article-title":"Depression in palliative care: a pragmatic report from the Expert Working Group of the European Association for Palliative Care.","volume":"9","author":"R Stiefel","year":"2001","journal-title":"Support Care Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.psy.50.4.383","article-title":"Mixed anxiety\/depression symptoms in a large cancer cohort: prevalence by cancer type.","volume":"50","author":"KM Brintzenhofe-Szoc","year":"2009","journal-title":"Psychosomatics"},{"key":"ref29","first-page":"S21","article-title":"[Understanding patients to promote self-regulation in Type 2 diabetes: how to live with an illness beginning before its onset?].","volume":"29","author":"S Sultan","year":"2003","journal-title":"Diabetes Metab"},{"key":"ref30","first-page":"901","article-title":"[A role of various components of the diffuse neuroendocrine system in the realization of magnetobiological effects].","volume":"46","author":"NA Temur'iants","year":"2001","journal-title":"Biofizika"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jad.2009.04.014","article-title":"Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.","volume":"120","author":"A Tadic","year":"2010","journal-title":"J Affect Disord"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"II13","DOI":"10.1007\/BF03035121","article-title":"Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale.","volume":"251","author":"HJ Moller","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref33","first-page":"39","article-title":"Major depressive disorder: gender differences in symptoms, life quality, and sexual function.","volume":"31","author":"CH Lai","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jad.2009.09.022","article-title":"Cognitive and anxiety symptoms in screening for clinical depression in diabetes: a systematic examination of diagnostic performances of the HADS and BDI-SF.","volume":"123","author":"S Sultan","year":"2010","journal-title":"J Affect Disord"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0033291709990997","article-title":"Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis.","volume":"40","author":"EJ Martens","year":"2010","journal-title":"Psychol Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/JCP.0b013e3181da5300","article-title":"Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.","volume":"30","author":"JD Amsterdam","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"ref37","first-page":"1559","article-title":"Anxiety and depression: a common feature of health care seeking patients with irritable bowel syndrome and food allergy.","volume":"45","author":"G Addolorato","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000234197","article-title":"The role of mast cells in inflammatory processes: evidence for nerve\/mast cell interactions.","volume":"82","author":"J Bienenstock","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"18053","DOI":"10.1073\/pnas.0809479105","article-title":"Brain mast cells link the immune system to anxiety-like behavior.","volume":"105","author":"KM Nautiyal","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0335-7457(01)00124-1","article-title":"Relationships between mast cells and the nervous system.","volume":"42","author":"J Bienenstock","year":"2002","journal-title":"Revue Fran\u00e7aise d'Allergologie et d'Immunologie Clinique"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0889-1591(02)00021-1","article-title":"Stress and the inflammatory response: a review of neurogenic inflammation.","volume":"16","author":"PH Black","year":"2002","journal-title":"Brain Behav Immun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbi.2007.01.002","article-title":"Role of mast cell degranulation in the neural correlates of the immediate allergic reaction in a murine model of asthma.","volume":"21","author":"FA Costa-Pinto","year":"2007","journal-title":"Brain Behav Immun"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/jpet.102.038497","article-title":"Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress.","volume":"303","author":"P Esposito","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-8993(00)03026-2","article-title":"Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.","volume":"888","author":"P Esposito","year":"2001","journal-title":"Brain Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2003.10.041","article-title":"Critical role of mast cells in inflammatory diseases and the effect of acute stress.","volume":"146","author":"TC Theoharides","year":"2004","journal-title":"J Neuroimmunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/039463200902200401","article-title":"Autism spectrum disorders and mastocytosis.","volume":"22","author":"T Theoharides","year":"2009","journal-title":"Int J Immunopathol Pharmaco"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0024-3205(90)90129-F","article-title":"Mast cells: the immune gate to the brain.","volume":"46","author":"TC Theoharides","year":"1990","journal-title":"Life Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1210\/endo.136.12.7588332","article-title":"Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect.","volume":"136","author":"TC Theoharides","year":"1995","journal-title":"Endocrinology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/210756b0","article-title":"Mast cells in the central nervous system.","volume":"210","author":"DJ Campbell","year":"1966","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/brbi.1998.0505","article-title":"Increased number of mast cells in the central nervous system of adult male mice following chronic subordination stress.","volume":"12","author":"F Cirulli","year":"1998","journal-title":"Brain Behav Immun"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.194.1.71","article-title":"Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs.","volume":"194","author":"I Matsumoto","year":"2001","journal-title":"J Exp Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2005.10.002","article-title":"Neuroimmunoendocrine circuitry of the \u2018brain-skin connection\u2019.","volume":"27","author":"R Paus","year":"2006","journal-title":"Trends Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0404.1991.tb04708.x","article-title":"Loss of psychic self-activation with bithalamic infarction. Neurobehavioural, CT, MRI and SPECT correlates.","volume":"83","author":"J Bogousslavsky","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"ref54","first-page":"439","article-title":"[Combined lesions of ventro-medial hypothalamus and dorso-medial thalamus: effects on interspecific social behavior, emotional reactivity and feeding behavior in the rat].","volume":"166","author":"F Eclancher","year":"1972","journal-title":"C R Seances Soc Biol Fil"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neubiorev.2008.10.001","article-title":"Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis.","volume":"33","author":"WX Ng","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2010.07.002","article-title":"Deep brain stimulation: from neurology to psychiatry?","volume":"33","author":"P Krack","year":"2010","journal-title":"Trends Neurosci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/npp.2009.104","article-title":"Neurocircuitry of mood disorders.","volume":"35","author":"JL Price","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.psyneuen.2007.10.008","article-title":"Identification and treatment of symptoms associated with inflammation in medically ill patients.","volume":"33","author":"R Dantzer","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior.","volume":"21","author":"R Dantzer","year":"2007","journal-title":"Brain Behav Immun"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291709005558","article-title":"Not fade away: the HPA axis and depression.","volume":"40","author":"PJ Cowen","year":"2010","journal-title":"Psychological Medecine"},{"key":"ref61","first-page":"291","article-title":"Mastocytosis (Mast cell disease).","year":"2001"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2396; author reply 2397-2398","DOI":"10.1176\/appi.ajp.162.12.2396","article-title":"Why the Hamilton Depression Rating Scale endures.","volume":"162","author":"P Bech","year":"2005","journal-title":"Am J Psychiatry"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jclp.20213","article-title":"Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung.","volume":"62","author":"AB Shafer","year":"2006","journal-title":"J Clin Psychol"},{"key":"ref64","first-page":"199","article-title":"[Factorial structure of the Hamilton depression scale. I.].","volume":"139","author":"JD Guelfi","year":"1981","journal-title":"Ann Med Psychol (Paris)"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"II6","DOI":"10.1007\/BF03035120","article-title":"Standardizing the Hamilton Depression Rating Scale: past, present, and future.","volume":"251","author":"JB Williams","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1037\/1040-3590.7.4.472","article-title":"Reliability and validity of the Hamilton Depression Inventory: A paper-pendil version of the Hamilton Depression Rating Scale interview.","volume":"7","author":"WM Reynolds","year":"1995","journal-title":"Psychological Assessment"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/02841869209108178","article-title":"Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients.","volume":"31","author":"K Bjordal","year":"1992","journal-title":"Acta Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0026375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T10:53:04Z","timestamp":1560855184000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0026375"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,21]]},"references-count":67,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0026375","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,21]]}}}